Clinical trials
Observational Dry Eye Syndromes trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 6 |
| 2010 | 4 |
| 2011 | 6 |
| 2012 | 6 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 2 |
| 2018 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
| Recruiting | 6 |
| Terminated | 5 |
| Unknown status | 3 |
| Withdrawn | 2 |
| Suspended | 2 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| TearLab Corporation | 4 |
| Allergan | 3 |
| Johns Hopkins University | 3 |
| National Eye Institute (NEI) | 3 |
| Tufts Medical Center | 3 |
| AbbVie | 2 |
| Alcon Research | 2 |
| Food and Drug Administration (FDA) | 2 |
| Ophthalmic Consultants of Long Island | 2 |
| Rapid Pathogen Screening | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dry Eye Syndromes | 61 |
| Sjogren's Syndrome | 7 |
| Corneal Diseases | 3 |
| Astigmatism | 2 |
| Cataract | 2 |
| Eye Diseases | 2 |
| Glaucoma | 2 |
| Hyperopia | 2 |
| Keratoconjunctivitis Sicca | 2 |
| Keratoconus | 2 |
Trials
Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.